COVID-19 in pregnancy increases babies’ risk of developmental delays, early study finds

Babies born to mothers who had COVID-19 during pregnancy were more likely to be diagnosed with a neurodevelopmental disorder by their first birthday compared to those born to mothers who did not have COVID-19, according to preliminary findings published June 9 in JAMA Network Open.

Advertisement

Researchers from Massachusetts General Hospital and Mass General Brigham, both based in Boston, used EHR data to analyze the births of 7,772 babies born in 2020 across six Massachusetts hospitals. Of those, 222 were born to mothers who tested positive for COVID-19 while pregnant. 

About 6 percent of babies who were exposed to COVID-19 in the womb received a neurodevelopmental diagnosis, most of which reflected motor or speech delays, within a year, compared to 3 percent among the unexposed cohort. Risks appeared to be higher when COVID-19 was contracted during the third trimester, the study said. 

Researchers were unable to assess the effect of vaccination, since the births took place before COVID-19 vaccines were available, and called for additional studies that explore how COVID-19 exposure affects fetal brain development. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Patient Safety & Outcomes

Advertisement

Comments are closed.